# STAAR Surgical Co (STAA) · Edgar & Edgarette company card

> STAAR Surgical (STAA) saw revenue fall 23.7% in FY2026 to $239 million, operating margin -38.3% against a 5.9% median for ophthalmic goods, equity 76.2% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 718937 · fiscal year ended 2026-01-02 · 5 audited years read · [page](https://www.pops4.com/boards/company/STAA) · [JSON](https://www.pops4.com/boards/company/STAA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $239M |
| Revenue growth, 1 year | -23.7% |
| Revenue growth per year | 1.0% |
| Operating margin | -38.3% (prior year -4.0%) |
| Net margin | -33.6% |
| Operating cash flow | −$34M |
| Capital spending | $6M |
| Free cash flow | −$40M |
| Cash | $153M |
| Long-term debt | — |
| Total assets | $452M |
| Total equity | $344M |
| Equity ÷ assets | 76.2% |
| Return on equity | -23.4% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.46 (safe zone)
- Piotroski F: 2 of 9 (weak)
- Beneish M: -3.32 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; operating cash flow was negative; operating loss: a margin of -38.3% in FY2026; revenue is hard to predict: its 80% range is ±29%
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $239.4M (FY2026). Experience: revenue down 23.7% on the year, up 1.0% a year over 4 years; operating margin -38.3%, down from -4.0%. Soundness: equity 76.2% of assets, return on equity -23.4%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $154.4M and $278.7M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $133.0M to $325.6M. A statistical range, not company guidance. Against peers (147 filers, $50M+ revenue, its industry group): operating margin -38.3% against a 5.9% median; growth -23.7% against 7.9%.

Range logged 2026-09-25, receipt 13d698ef95dcf816, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-01-15 ([filing](https://www.sec.gov/Archives/edgar/data/718937/000119312526013622/0001193125-26-013622-index.htm))
- Item 5.02 Director or officer change: 8, latest 2026-09-10 ([filing](https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/0001193125-26-386662-index.htm))

## Recent filings

- 8-K · filed 2026-09-10 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/0001193125-26-386662-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/718937/000071893726000037/0000718937-26-000037-index.htm)
- 8-K · filed 2026-08-12 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/718937/000071893726000036/0000718937-26-000036-index.htm)
- 8-K · filed 2026-08-06 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/0001193125-26-337197-index.htm)
- 8-K · filed 2026-06-22 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/718937/000071893726000029/0000718937-26-000029-index.htm)
- 8-K · filed 2026-06-09 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/718937/000071893726000027/0000718937-26-000027-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000718937.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=718937

## Cite

POPS4, Edgar & Edgarette: STAAR Surgical Co (STAA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/STAA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.